The histamine H4 receptor as a new therapeutic target for inflammation

Trends in Pharmacological Sciences

Volumn 26, Issue 9, 2005, Pages 462-469

  De Esch, Iwan J P ^a   Thurmond, Robin L ^b   Jongejan, Aldo ^a   Leurs, Rob ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(5 CHLORO 1H BENZ[D]IMIDAZOL 2 YL)(4 METHYLPIPERAZIN 1 YL)METHADONE; 1 [(5 CHLORO 1H INDOL 2 YL)CARBONYL] 4 METHYLPIPERAZINE; 2 CYANO 1 METHYL 3 [5 [1H IMIDAZOL 4(5) YL]TETRAHYDROFURAN 2 YL]METHYLGUANIDINE; 4 METHYLHISTAMINE; ALPHA METHYLHISTAMINE; ANTIHISTAMINIC AGENT; BURIMAMIDE; CLOBENPROPIT; HISTAMINE; HISTAMINE AGONIST; HISTAMINE H4 RECEPTOR; HISTAMINE H4 RECEPTOR ANTAGONIST; IMETIT; IMMEPIP; JNJ 7777120; OUP 16; THIOPERAMIDE; UNCLASSIFIED DRUG; VUF 6002; CALCIUM; G PROTEIN COUPLED RECEPTOR; HISTAMINE RECEPTOR; HRH4 PROTEIN, HUMAN;

AMINO ACID SEQUENCE; DRUG POTENCY; DRUG SELECTIVITY; DRUG TARGETING; HUMAN; INFLAMMATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PERITONITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PRURITUS; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; DRUG ANTAGONISM; DRUG POTENTIATION; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY;

AMINO ACID SEQUENCE; ANIMALS; CALCIUM; HUMANS; INFLAMMATION; MOLECULAR SEQUENCE DATA; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, HISTAMINE; SIGNAL TRANSDUCTION;

EID: 23944456700     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2005.07.002     Document Type: Review

References (59)

1. S.J. Hill International Union of Pharmacology. XIII. Classification of histamine receptors Pharmacol. Rev. 49 1997 253 278
2. 3 receptor Mol. Pharmacol. 55 1999 1101 1107
3. 3 receptor as a novel therapeutic target for cognitive and sleep disorders Trends Pharmacol. Sci. 25 2004 618 625
4. 3 receptor drugs Nat. Rev. Drug Discov. 4 2005 107 120
5. T. Oda Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes J. Biol. Chem. 275 2000 36781 36786
6. 4R Biochem. Biophys. Res. Commun. 279 2000 615 620
7. Y. Zhu Cloning, expression, and pharmacological characterization of a novel human histamine receptor Mol. Pharmacol. 59 2001 434 441
8. T. Nguyen Discovery of a novel member of the histamine receptor family Mol. Pharmacol. 59 2001 427 433
9. K.L. Morse Cloning and characterization of a novel human histamine receptor J. Pharmacol. Exp. Ther. 296 2001 1058 1066
10. 4) expressed in bone marrow Mol. Pharmacol. 59 2001 420 426
11. 4 receptor on human eosinophils-role in eosinophil chemotaxis J. Recept. Signal Transduct. Res. 22 2002 431 448
12. 4-receptor gene Biochem. Biophys. Res. Commun. 284 2001 301 309
13. 3 receptor heterogeneity Life Sci. 73 2003 3043 3072
14. J.M. Baldwin An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors J. Mol. Biol. 272 1997 144 164
15. T. Mirzadegan Sequence analysis of G-protein-coupled receptors: similarities to rhodopsin Biochemistry 42 2003 2759 2767
16. J.A. Ballesteros, and H. Weinstein Integrated methods for the construction of three-dimensional models of structure-function relations in G protein-coupled receptors Methods Neurosci. 25 1995 366 428
17. E.S. Huang Construction of a sequence motif characteristic of aminergic G protein-coupled receptors Protein Sci. 12 2003 1360 1367
18. 4 receptors reveals substantial pharmacological species variation J. Pharmacol. Exp. Ther. 299 2001 121 130
19. 4 receptor Biochim. Biophys. Acta 1575 2002 135 138
20. L.B. Hough Genomics meets histamine receptors: new subtypes, new receptors Mol. Pharmacol. 59 2001 415 419
21. 4 receptor J. Immunol. 173 2004 2078 2083
22. 3 receptors regulates histamine neurons in brain Nature 408 2000 860 864
23. 3 antagonists J. Pharmacol. Exp. Ther. 299 2001 908 914
24. 2 receptors Proc. Natl. Acad. Sci. U. S. A. 93 1996 6802 6807
25. 1 receptor antagonists Eur. J. Pharmacol. 387 2000 R5 R7
26. 4 receptor mediates chemotaxis and calcium mobilization of mast cells J. Pharmacol. Exp. Ther. 305 2003 1212 1221
27. R.A. Clark Histamine modulation of eosinophil migration J. Immunol. 118 1977 137 145
28. D.G. Raible Mast cell mediators prostaglandin-D2 and histamine activate human eosinophils J. Immunol. 148 1992 3536 3542
29. D.G. Raible Pharmacologic characterization of a novel histamine receptor on human eosinophils Am. J. Respir. Crit. Care Med. 149 1994 1506 1511
30. 4 receptor Br. J. Pharmacol. 140 2003 1117 1127
31. 4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation Br. J. Pharmacol. 142 2004 161 171
32. 4 receptor antagonists J. Med. Chem. 46 2003 3957 3960
33. 3 receptor agonist J. Med. Chem. 47 2004 2414 2417
34. 3 receptor agonist J. Med. Chem. 48 2005 2100 2107
35. 3 receptor antagonists Bioorg. Med. Chem. Lett. 12 2002 3309 3312
36. 3 receptor antagonists Bioorg. Med. Chem. Lett. 13 2003 1325 1328
37. 4-receptor agonist: (-)-2-cyano-1-methyl-3-[(2R,5R)-5-[1H-imidazol-4(5)-yl]tetrahydrofuran-2-y] methylguanidine J. Med. Chem. 46 2003 3162 3165
38. 4 receptor agonist. J. Pharmacol. Exp. Ther. (in press) (DOI: 0.1124/jpet.105.087965)
39. 4 receptor antagonists Bioorg. Med. Chem. Lett. 14 2004 5251 5256
40. 4 receptor antagonist with anti-inflammatory properties J. Pharmacol. Exp. Ther. 309 2004 404 413
41. 4 receptor Mol. Pharmacol. 62 2002 38 47
42. L. Shi, and J.A. Javitch The binding site of aminergic G protein-coupled receptors: the transmembrane segments and second extracellular loop Annu. Rev. Pharmacol. Toxicol. 42 2002 437 467
43. 1-receptor agonists Biochem. Biophys. Res. Commun. 201 1994 295 301
44. 3 receptors J. Invest. Dermatol. 123 2004 116 123
45. D. Voehringer Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production Immunity 20 2004 267 277
46. +T cells J. Pharmacol. Exp. Ther. 303 2002 300 307
47. 4 receptor during rat development. XXXIII Ann. Meet. Eur. Histamine Res. Soc P6-11
48. M. Nakaya Immunohistochemical localization of histamine receptor subtypes in human inferior turbinates Ann Otol Rhinol Laryngol 113 2004 552 557
49. R.A.F. Clark Selective eosinophil chemotactic activity of histamine J. Exp. Med. 142 1975 1462 1476
50. W.J. Fokkens Dynamics of mast cells in the nasal mucosa of patients with allergic rhinitis and non-allergic controls: a biopsy study Clin. Exp. Allergy 22 1992 701 710
51. A. Slater Increase in epithelial mast cell numbers in the nasal mucosa of patients with perennial allergic rhinitis J. Laryngol. Otol. 110 1996 929 933
52. 4 antagonism: a therapy for chronic allergy? Br. J. Pharmacol. 142 2004 5 7
53. 4 ligands Mini Rev. Med. Chem. 4 2004 993 1000
54. 4 receptor antagonists: the new antihistamines? Curr. Opin. Investig. Drugs 5 2004 1174 1183
55. 4 production and mast cell-dependent neutrophil recruitment induced by zymosan in vivo J. Pharmacol. Exp. Ther. 307 2003 1072 1078
56. 4 receptor in zymosan-induced neutrophil recruitment from the bone marrow: comparison with carrageenan J. Pharmacol. Exp. Ther. 310 2004 272 280
57. O. Hagermark Peripheral and central mediators of itch Skin Pharmacol. 5 1992 1 8
58. 1 receptors in scratching induced by histamine receptor agonists in BalbC mice Br. J. Pharmacol. 142 2004 374 380
59. W. Kabsch, and C. Sander Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features Biopolymers 22 1983 2577 2637